Treace
Highly Engaged Employees
Highly Engaged EmployeesManufacturing · Florida, United States · 201-500 Employees
View Company Info for Free
Overview
Headquarters
100 Palmetto Park Poland, Ponte Vedra, F...Phone Number
(904) 373-5940Website
www.treace.comRevenue
$207.3 MillionStock Symbol
TMCIIndustry
ZI Rank: 1
Signal Type
Dec
Jan
Feb
Mar
Apr
May
ZI Rank
5
4
1
1
1
1
About Treace
Treace Medical Concepts is an orthopedic medical device company focused on the surgical correction of bunions and related midfoot deformities. Its flagship Lapiplasty 3D Bunion Correction System and associated implants, instruments, and surgical techniques are designed to correct bunions in three dimensions at the root cause, along with complementary products addressing related foot and ankle pathologies. Treace sells primarily to orthopedic surgeons and hospitals/ASCs in the U.S. and select international markets.Explore more
Treace Org Chart
Get the full picture
Sign in to uncover key details.
Show More
Sell smarter with deeper company insights.
ZoomInfo gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Is Treace your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Congratulate Masked Content for being promoted to Masked Content at Treace
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Funding: Get notified immidiatlly once Treace has new funding data
Check out if Treace is spiking on competitors!
Product Launch: Get notified when Treace launches new products
Click to see if Treace had a recent Job posting/layoffs
Website visits: Recent activity has been detected on your website
Earning: See what the market has to say on Treace recently announced quarterly report
Check if Treace has recently received funding, and reach out quickly before it becomes old news!
Treace, which may be a good buyer, showed buying intent in Masked Content Topic
Recommended Actions
Introduce yourself to Masked Content, who has shown a strong intent to purchase lately
Find 2 more new buyers
Compare Similar Companies to Treace
Compare insights from companies similar to Treace, focusing on performance, financial data, growth rates, and unique benchmarks to identify key industry trends and opportunities.
Revenue
Number of Employees
Type
Funding
Founded In
Company Profile Activity
Activity Insights
Treace is experiencing very low activity levels compared to other companies in the Manufacturing sector.
What does this means?
Treace is drawing exceptional interest within the Manufacturing industry, suggesting notable developments or strong market momentum, learn more about Treace.
Treace financials insights
Gather financial insights about Treace, including details on funding rounds, investors, total funding, and acquisitions, to gain a comprehensive understanding of their financial strategy.
2015
Private Equity
$7M
2017
Debt
$2.1M
Private Equity
$5.9M
2020
Debt
$1M
2021
Share Placement
$191M
2022
Debt
$150M
2025
Debt
$175M
Treace Tech Stack
A closer look at the technologies used by Treace
See more technologies
Most Recent Scoops
Person-Based
Stake & Stock Ownership, Acquisitions, Finance
Person-Based
Product Development, Sales
Person-Based
Earnings, Lawsuits, Legal Affairs, Finance
Person-Based
Earnings, Finance, Healthcare Technology
Person-Based
Product Development
Treace News & Media
Treace Medical Concepts Q1 Earnings Call Highlights
Treace Medical Concepts (NASDAQ:TMCI) reaffirmed its full-year 2026 revenue outlook after reporting a first-quarter revenue decline, as management said new product adoption is helping drive procedure volume momentum despite pricing and mix headwinds. On the company’s first-quarter earnings call, ChTreace Medical Concepts Reports First Quarter 2026 Financial Results
PONTE VEDRA, Fla., May 08, 2026 (GLOBE NEWSWIRE) -- Treace Medical Concepts, Inc. ("Treace" or the "Company") (NasdaqGS: TMCI), a medical technology company driving a fundamental shift in the surgical treatment of bunions and related midfoot deformities, today reported financial results for the first quarter ended March 31, 2026.Treace to Report First Quarter 2026 Financial Results on May 8, 2026
PONTE VEDRA, Fla., April 24, 2026 (GLOBE NEWSWIRE) -- Treace Medical Concepts, Inc. (“Treace” or the “Company”) (NasdaqGS: TMCI), a medical technology company driving a fundamental shift in the surgical treatment of bunions and related midfoot deformities, today announced that it will release financial results for the first quarter 2026 before the start of trading on Friday, May 8, 2026. Company management will host a conference call to discuss financial results beginning at 8:00 amTreace Announces First Surgical Cases with the SuperBite™ Compression Screw System
New portfolio addition taps into incremental procedures throughout the foot and ankle; strengthens Treace’s comprehensive suite of technologies for its growing customer base New portfolio addition taps into incremental procedures throughout the foot and ankle; strengthens Treace’s comprehensive suite of technologies for its growing customer base
Read more news
Top Manufacturing Companies
Top companies in Canada by revenue
Top companies in New Zealand by revenue
Frequently Asked Questions Regarding Treace
Sign Up For FreeTo access detailed company insights
Treace Medical Concepts is an orthopedic medical device company focused on the surgical correction of bunions and related midfoot deformities. Its flagship Lapiplasty 3D Bunion Correction System and associated implants, instruments, and surgical techniques are designed to correct bunions in three dimensions at the root cause, along with complementa... Read More
